Products for Research Use Only

Brimonidine

CAT: 1410-M27233-05Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M27233-05Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Brimonidine is a drug used as eye drops under the brand names Alphagan and Alphagan-P. It is used to treat open-angle glaucoma or ocular hypertension
CAS Number
59803-98-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
292.14
Molecular Formula
C11H10BrN5
Notes
Research use only, not for human use.
Receptor
5-HT Receptor| GlyT2| P2X Receptor

Chemical Information

Brimonidine

Brimonidine is a member of imidazoles, a secondary amine and a quinoxaline derivative. It has a role as an alpha-adrenergic agonist, an antihypertensive agent and an adrenergic agonist.

CAS Number59803-98-4
PubChem CID2435
IUPAC Name5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
Molecular FormulaC11H10BrN5
Molecular Weight292.13
XLogP0.6
Topological Polar Surface Area62.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Heavy Atom Count17
Formal Charge0
Complexity308
SMILES
C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
InChI
InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)
InChIKey
XYLJNLCSTIOKRM-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Brimonidine
CAS: 59803-98-4
CID: 2435
Formula: C11H10BrN5
MW: 292.13
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight292.13
XLogP30.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass291.01196
Monoisotopic Mass291.01196
Topological Polar Surface Area62.2 Ų
Heavy Atom Count17
Formal Charge0
Complexity308
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes